Invention Grant
- Patent Title: Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors
-
Application No.: US17018241Application Date: 2020-09-11
-
Publication No.: US11274152B2Publication Date: 2022-03-15
- Inventor: Alan J. Korman , Nils Lonberg , David J. Fontana , Andres A. Gutierrez , Mark J. Selby , Katherine Lewis
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/28 ; A61P35/00 ; A61K39/00
Abstract:
Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody.
Public/Granted literature
- US20210009692A1 Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Treat Tumors Public/Granted day:2021-01-14
Information query
